Aethon Therapeutics was born out of a novel cancer immunotherapy platform, dubbed HapImmune™, developed by Shohei Koide, Ph.D. and Benjamin G. Neel, M.D., Ph.D., researchers from NYU Langone Health's Perlmutter Cancer Center. Aethon was founded in..
Relevance: 21.568125